Systematic-Review-Drug-Efficiency-Dissertation-Sample-Work-Tutors-India
Idiopathic Pulmonary Fibrosis (IPF) as the name suggests is a progressive disorder with no known aetiology. It is characterised by the thickening of the alveoli due to scarring resulting in cough. It is known to primarily occur in older adults over 60 years of age. The findings of IPF have a known association of Usual Interstitial Pneumonia (UIP) (Raghu et al., 2011; Kawano-Dourado & Kairalla, 2013; Wells, 2013). It has been deemed that the prognosis is generally poor when UIP has been confirmed (King et al., 2001b). The median survival rate of IPF is 50%, typically around two years after diagnosis (Raghu et al., 2011; King et al., 2001b).
Idiopathic Pulmonary Fibrosis (IPF) as the name suggests is a progressive disorder with no known aetiology. It is characterised by the thickening of the alveoli due to scarring resulting in cough. It is known to primarily occur in older adults over 60 years of age. The findings of IPF have a known association of Usual Interstitial Pneumonia (UIP) (Raghu et al., 2011; Kawano-Dourado & Kairalla, 2013; Wells, 2013). It has been deemed that the prognosis is generally poor when UIP has been confirmed (King et al., 2001b). The median survival rate of IPF is 50%, typically around two years after diagnosis (Raghu et al., 2011; King et al., 2001b).
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
El-Chemaly, S., Ziegler, S.G., Calado, R.T., Wilson, K.A., Wu, H.P., Haughey, M., Peterson,<br />
N.R., Young, N.S., Gahl, W.A., Moss, J. & Gochuico, B.R. (2011). Natural History of<br />
Pulmonary Fibrosis in Two Subjects With the Same Telomerase Mutation. Chest.<br />
[Online]. 139 (5). pp. 1203–1209. Available from:<br />
http://linkinghub.elsevier.com/retrieve/pii/S0012369211602468.<br />
Enomoto, N., Suda, T., Kato, M., Kaida, Y., Nakamura, Y., Imokawa, S., Ida, M. & Chida, K.<br />
(2006). Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest.<br />
[Online]. 130 (1). pp. 22–9. Available from:<br />
http://www.ncbi.nlm.nih.gov/pubmed/16840378.<br />
Erbes, R., Schaberg, T. & Loddenkemper, R. (1997). Lung function tests in patients with<br />
idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest. [Online].<br />
111 (1). pp. 51–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8995992.<br />
Esposito, D.B., Lanes, S., Donneyong, M., Holick, C.N., Lasky, J.A., Lederer, D., Nathan,<br />
S.D., O’Quinn, S., Parker, J. & Tran, T.N. (2015). Idiopathic Pulmonary Fibrosis in<br />
United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.<br />
American journal of respiratory and critical care medicine. [Online]. 192 (10). pp.<br />
1200–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26241562.<br />
Von Essen, S., Robbins, R.A., Thompson, A.B. & Rennard, S.I. (1990). Organic dust toxic<br />
syndrome: an acute febrile reaction to organic dust exposure distinct from<br />
hypersensitivity pneumonitis. Journal of toxicology. Clinical toxicology. 28 (4). pp.<br />
389–420.<br />
Fanta, C.H. (1985). Clinical aspects of mucus and mucous plugging in asthma. The Journal<br />
of asthma : official journal of the Association for the Care of Asthma. 22 (6). pp. 295–<br />
301.<br />
Fell, C.D. & Martinez, F.J. (2007). The impact of pulmonary arterial hypertension on<br />
idiopathic pulmonary fibrosis. Chest. 131 (3). pp. 641–3.<br />
Fell, C.D., Martinez, F.J., Liu, L.X., Murray, S., Han, M.K., Kazerooni, E.A., Gross, B.H.,<br />
Myers, J., Travis, W.D., Colby, T. V, Toews, G.B. & Flaherty, K.R. (2010). Clinical<br />
© 2017-2018 All Rights Reserved, No part of this document should be modified/used without prior consent<br />
<strong>Tutors</strong> <strong>India</strong> - Your trusted mentor since 2001<br />
www.tutorindia.com I UK # +44-1143520021, info@tutorsindia.com<br />
Page 123 of 172
Change language